State Street’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,774
| Closed | -$61.7K | – | 4298 |
|
|
2025
Q1 | $61.7K | Hold |
9,774
| – | – | ﹤0.01% | 4061 |
|
|
2024
Q4 | $101K | Hold |
9,774
| – | – | ﹤0.01% | 3986 |
|
|
2024
Q3 | $126K | Buy |
9,774
+4,578
| +88% | +$58.8K | ﹤0.01% | 3932 |
|
|
2024
Q2 | $71.9K | Buy |
5,196
+2,672
| +106% | +$37K | ﹤0.01% | 4080 |
|
|
2024
Q1 | $785K | Buy |
2,524
+340
| +16% | +$106K | ﹤0.01% | 3530 |
|
|
2023
Q4 | $572K | Buy |
2,184
+282
| +15% | +$73.9K | ﹤0.01% | 3615 |
|
|
2023
Q3 | $372K | Buy |
1,902
+786
| +70% | +$154K | ﹤0.01% | 3735 |
|
|
2023
Q2 | $229K | Buy |
1,116
+364
| +48% | +$74.8K | ﹤0.01% | 3960 |
|
|
2023
Q1 | $77.8K | Hold |
752
| – | – | ﹤0.01% | 4395 |
|
|
2022
Q4 | $118K | Buy |
752
+51
| +7% | +$8K | ﹤0.01% | 4320 |
|
|
2022
Q3 | $176K | Buy |
701
+16
| +2% | +$4.02K | ﹤0.01% | 4209 |
|
|
2022
Q2 | $193K | Buy |
+685
| New | +$193K | ﹤0.01% | 4211 |
|
|
2021
Q2 | – | Sell |
-1,925
| Closed | -$1.12M | – | 4482 |
|
|
2021
Q1 | $1.12M | Buy |
1,925
+372
| +24% | +$215K | ﹤0.01% | 3600 |
|
|
2020
Q4 | $885K | Buy |
1,553
+643
| +71% | +$366K | ﹤0.01% | 3576 |
|
|
2020
Q3 | $509K | Buy |
910
+61
| +7% | +$34.1K | ﹤0.01% | 3571 |
|
|
2020
Q2 | $481K | Buy |
+849
| New | +$481K | ﹤0.01% | 3545 |
|